| Targeting PARP and autophagy evoked synergistic lethality in hepatocellular carcinoma W Zai, W Chen, Y Han, Z Wu, J Fan, X Zhang, J Luan, S Tang, X Jin, X Fu, ... Carcinogenesis 41 (3), 345-357, 2020 | 34 | 2020 |
| Curdione ameliorated doxorubicin-induced cardiotoxicity through suppressing oxidative stress and activating Nrf2/HO-1 pathway Z Wu, W Zai, W Chen, Y Han, X Jin, H Liu Journal of Cardiovascular Pharmacology 74 (2), 118-127, 2019 | 26 | 2019 |
| Establishment and characterization of highly osteolytic luminal breast cancer cell lines by intracaudal arterial injection Y Han, J Nakayama, Y Hayashi, S Jeong, M Futakuchi, E Ito, S Watanabe, ... Genes to Cells 25 (2), 111-123, 2020 | 25 | 2020 |
| A regulatory insertion-deletion polymorphism in the FADS gene cluster influences PUFA and lipid profiles among Chinese adults: a population-based study P Li, J Zhao, KSD Kothapalli, X Li, H Li, Y Han, S Mi, W Zhao, Q Li, ... The American Journal of Clinical Nutrition 107 (6), 867-875, 2018 | 24 | 2018 |
| High sensitivity in vivo imaging of cancer metastasis using a near-infrared luciferin analogue seMpai J Nakayama, R Saito, Y Hayashi, N Kitada, S Tamaki, Y Han, K Semba, ... International journal of molecular sciences 21 (21), 7896, 2020 | 22 | 2020 |
| The in vivo selection method in breast cancer metastasis J Nakayama, Y Han, Y Kuroiwa, K Azuma, Y Yamamoto, K Semba International journal of molecular sciences 22 (4), 1886, 2021 | 21 | 2021 |
| Metastatic profiling of HER2-positive breast cancer cell lines in xenograft models Y Han, K Azuma, S Watanabe, K Semba, J Nakayama Clinical & Experimental Metastasis 39 (3), 467-477, 2022 | 5 | 2022 |
| Targeting c-Jun is a potential therapy for luminal breast cancer bone metastasis Y Han, S Katayama, M Futakuchi, K Nakamichi, Y Wakabayashi, ... Molecular Cancer Research 21 (9), 908-921, 2023 | 2 | 2023 |
Jun NakayamaOsaka International Cancer Institute確認したメール アドレス: oici.jp
Jun NakayamaOsaka International Cancer Institute確認したメール アドレス: oici.jp